Patents by Inventor Oliver Rixe

Oliver Rixe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EGFRvIII immunogen and methods for using same
    Patent number: 11530242
    Abstract: An immunogen includes an antigenic EGFRvIII peptide linked to a Q? bacteriophage virus-like particle (VLP) carrier. The antigenic EGFRvIII peptide has at least 53%, at least 61%, at least 69%, at least 76%, at least 84%, or at least 92% sequence similarity amino acid similarity to LEEKKGNYVVTDH (SEQ ID NO:1).
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: December 20, 2022
    Inventors: Bryce Chackerian, Oliver Rixe
  • EGFRvIII IMMUNOGEN AND METHODS FOR USING SAME
    Publication number: 20210253641
    Abstract: An immunogen includes an antigenic EGFRvIII peptide linked to a Q? bacteriophage virus-like particle (VLP) carrier. The antigenic EGFRvIII peptide has at least 53%, at least 61%, at least 69%, at least 76%, at least 84%, or at least 92% sequence similarity amino acid similarity to LEEKKGNYVVTDH (SEQ ID NO:1).
    Type: Application
    Filed: July 16, 2019
    Publication date: August 19, 2021
    Inventors: Bryce Chackerian, Oliver Rixe